UNSPSC 51283805: Virginiamycin

This classification denotes a depsipeptide antibiotic with the molecular formula C43H49N7O10, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier C49WS9N75L, more generally known as virginiamycin. European Medicines Agency schedules virginiamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05111MIG. The term VIRGINIAMYCIN is an International Non-Proprietary Name or INN. see World Health Organization INN reference publication, volume 22, no. 10, 1968, list 8.

VIRGINIAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51283805 Virginiamycin, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code designates a specific antimicrobial feed additive used primarily in animal agriculture, yet the recent opportunities flagged under this code involve naloxone kits, safe drug deactivation systems, first-aid supplies, and multi-source generic pharmaceuticals—none of which relate to virginiamycin or its veterinary applications. State and local procurement systems occasionally misclassify opportunities during posting, and this code appears to reflect such a mismatch rather than genuine market demand for the product itself.

The source provides no evidence of current state or local procurement activity for virginiamycin as a commodity. The issuing bodies represented—Seminole County (Florida), the Texas Health and Human Services Commission, the City of Tampa, and the Minnesota Multistate Cooperative Purchasing Alliance—are sourcing pharmaceutical, medical supply, and drug management products entirely outside the scope of animal feed additives. Without recent opportunities genuinely soliciting virginiamycin, characterization of issuing-body concentration, geographic spread, or representative work is not supported by the source. Firms evaluating this code should confirm whether their target customers are actually buying virginiamycin through state and local procurement channels or whether the mismatch signals that activity under this code is currently absent from the market.